These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 18346292
1. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. Vieta E, Cruz N, García-Campayo J, de Arce R, Manuel Crespo J, Vallès V, Pérez-Blanco J, Roca E, Manuel Olivares J, Moríñigo A, Fernández-Villamor R, Comes M. Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292 [Abstract] [Full Text] [Related]
2. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842 [Abstract] [Full Text] [Related]
3. Oxcarbazepine for acute affective episodes in bipolar disorder. Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH. Cochrane Database Syst Rev; 2011 Dec 07; (12):CD004857. PubMed ID: 22161387 [Abstract] [Full Text] [Related]
4. A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder. Vieta E, Manuel Goikolea J, Martínez-Arán A, Comes M, Verger K, Masramon X, Sanchez-Moreno J, Colom F. J Clin Psychiatry; 2006 Mar 07; 67(3):473-7. PubMed ID: 16649836 [Abstract] [Full Text] [Related]
5. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial. Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I. J Clin Psychiatry; 2012 Nov 07; 73(11):1412-9. PubMed ID: 23218157 [Abstract] [Full Text] [Related]
6. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA, LamLit Study Group. J Clin Psychiatry; 2009 Feb 07; 70(2):223-31. PubMed ID: 19200421 [Abstract] [Full Text] [Related]
7. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Loebel A, Cucchiaro J, Silva R, Kroger H, Sarma K, Xu J, Calabrese JR. Am J Psychiatry; 2014 Feb 07; 171(2):169-77. PubMed ID: 24170221 [Abstract] [Full Text] [Related]
8. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. Weisler RH, Kalali AH, Ketter TA, SPD417 Study Group. J Clin Psychiatry; 2004 Apr 07; 65(4):478-84. PubMed ID: 15119909 [Abstract] [Full Text] [Related]
9. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies. Zhang ZJ, Kang WH, Li Q, Tan QR. J Psychiatr Res; 2007 Nov 07; 41(10):828-36. PubMed ID: 17010995 [Abstract] [Full Text] [Related]
11. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. Weisler RH, Keck PE, Swann AC, Cutler AJ, Ketter TA, Kalali AH, SPD417 Study Group. J Clin Psychiatry; 2005 Mar 07; 66(3):323-30. PubMed ID: 15766298 [Abstract] [Full Text] [Related]
12. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I (Trial 001) Investigators. J Clin Psychiatry; 2010 Feb 07; 71(2):150-62. PubMed ID: 20122369 [Abstract] [Full Text] [Related]
13. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder. Kemp DE, Gao K, Fein EB, Chan PK, Conroy C, Obral S, Ganocy SJ, Calabrese JR. Bipolar Disord; 2012 Nov 07; 14(7):780-9. PubMed ID: 23107222 [Abstract] [Full Text] [Related]
14. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N, Mullen J, Paulsson B, Vågerö M. J Affect Disord; 2007 Nov 07; 100 Suppl 1():S55-63. PubMed ID: 17383736 [Abstract] [Full Text] [Related]
15. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study. Wang Z, Gao K, Kemp DE, Chan PK, Serrano MB, Conroy C, Fang Y, Ganocy SJ, Findling RL, Calabrese JR. Psychopharmacol Bull; 2010 Nov 07; 43(4):5-21. PubMed ID: 21240149 [Abstract] [Full Text] [Related]
19. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder. Suppes T, Kelly DI, Hynan LS, Snow DE, Sureddi S, Foster B, Curley E. Aust N Z J Psychiatry; 2007 May 07; 41(5):397-402. PubMed ID: 17464731 [Abstract] [Full Text] [Related]
20. The empirical redefinition of the psychometric criteria for remission in bipolar disorder. Berk M, Ng F, Wang WV, Calabrese JR, Mitchell PB, Malhi GS, Tohen M. J Affect Disord; 2008 Feb 07; 106(1-2):153-8. PubMed ID: 17655936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]